What is it about?
Fluid overload is increasingly common across CKD stages and almost universal in patients who start regular dialysis treatment. Clinical signs like peripheral edema or hypertension are insensitive indicators of fluid overload. Optimization of fluid volume in CKD and in dialysis patients should be ideally guided not only by the BP response to low sodium diet and diuretics and to ultrafiltration by dialysis but also by objective measurements of fluid status such as bio-impedance spectroscopy (BIS) and by an ultrasound (US) technique estimating lung water. Testing well-integrated, multi-level interventions aimed at improving patients adherence to low sodium and treatment policies guided by BIS and lung US represent a true priority for clinical research in nephrology.
Featured Image
Read the Original
This page is a summary of: Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease, Clinical Journal of the American Society of Nephrology, August 2018, American Society of Nephrology,
DOI: 10.2215/cjn.01360118.
You can read the full text:
Contributors
The following have contributed to this page